Response of complex immune-mediated thrombocytopenia to romiplostim in the setting of allogeneic stem cell transplantation for chronic myelogenous leukemia-Reference-Cited by-同舟云学术

Response of complex immune-mediated thrombocytopenia to romiplostim in the setting of allogeneic stem cell transplantation for chronic myelogenous leukemia

Published:2012-08-18 Issue:4 Volume:89 Page:361-364
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur J Haematol

Author:

Bollag Roni J.¹,Sterett Meghan²,Reding Mark T.³,Key Nigel S.⁴,Cohn Claudia S.⁵,Ustun Celalettin³

Affiliation:

1. Department of Pathology; Medical College of Georgia; Augusta; GA; USA

2. Department of Medicine; Medical College of Georgia, Section of Hematology-Oncology; Augusta; GA; USA

3. Division of Hematology-Oncology and Transplantation; University of Minnesota; Minneapolis; MN; USA

4. Division of Hematology-Oncology; University of North Carolina; Chapel Hill; NC; USA

5. Laboratory Medicine and Pathology, Division of Transfusion Medicine; University of Minnesota Blood Bank Laboratory; Minneapolis; MN; USA

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-0609.2012.01832.x/fullpdf

Reference16 articles.

1. International consensus report on the investigation and management of primary immune thrombocytopenia;Provan;Blood,2010

2. Platelet refractoriness and alloimmunization;Slichter;Leukemia,1998

3. Severe autoimmune thrombocytopenic purpura during interferon-alpha therapy for chronic myelogenous leukemia;Arimura;Acta Haematol,2004

4. Imatinib mesylate induced immune thrombocytopenia;Rajappa;Leuk Lymphoma,2007

5. Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients;Slichter;Blood,2005

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thrombopoietin Receptor Agonists in Post-Hematopoietic Cell Transplantation Complicated by Prolonged Thrombocytopenia: A Comprehensive Review;ImmunoTargets and Therapy;2024-09

2. Thrombocytopenia and Therapeutic Strategies after Allogeneic Hematopoietic Stem Cell Transplantation;Journal of Clinical Medicine;2022-03-02

3. Phase I Dose-Finding, Safety, and Tolerability Trial of Romiplostim to Improve Platelet Recovery After UCB Transplantation;Transplantation and Cellular Therapy;2021-06

4. The Efficacy of Eltrombopag Treatment in Patients who developed Platelet Engraftment Failure after Allogeneic Stem Cell Transplantation: A Single Center Experience;Bezmialem Science;2021-01-25

5. Use of thrombopoietin receptor agonists after hematopoietic progenitor cell transplantation;ADVANCES IN CELL AND GENE THERAPY;2020-07-26